RETEVMO 80 mg/1 (Selpercatinib CAPSULE) 80 mg/1

RETEVMO 80 mg capsules contain selpercatinib, a medication used for targeted therapy. This oral treatment is designed to address specific conditions related to genetic mutations.

Strength

80 mg/1

Pack Size

120 CAPSULE in 1 BOTTLE (0002-2980-26)

Manufacturer / TM Owner

Eli Lilly and Company

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

RETEVMO 80 mg capsules are primarily used in the management of certain cancers associated with RET gene alterations. Selpercatinib is often prescribed for conditions where these genetic changes play a role. Patients and healthcare providers may explore 'what is RETevmo used for' to understand its applications in targeted therapy.

Side Effects

Common effects of RETevmo 80 mg capsules may include gastrointestinal issues, fatigue, and changes in taste. Some users might experience skin reactions or changes in blood pressure. Individual responses can vary, and it's important to discuss any concerns with a healthcare professional.

Precautions & Warnings

RETEVMO 80 mg capsules should be handled with care, following the guidance of a healthcare provider. It's essential to store the medication properly and adhere to prescribed usage. Patients should inform their healthcare provider about any existing medical conditions or other medications they are taking.

Avoid Interactions

RETEVMO 80 mg capsules may interact with certain medications, including those metabolized by the liver's CYP enzymes. Alcohol and other substances that affect liver function could potentially influence the effectiveness or safety of selpercatinib. Always consult a healthcare provider before combining RETevmo with other treatments.

Frequently Asked Questions

RETEVMO 80 mg capsules are used in the treatment of certain cancers linked to RET gene mutations. It is a targeted therapy designed to address specific genetic alterations.

RETEVMO 80 mg capsules are taken orally, typically as directed by a healthcare provider. Always follow the prescribed dosage and administration instructions.

Common side effects may include gastrointestinal issues, fatigue, and changes in taste. Some users might experience skin reactions or changes in blood pressure.

RETEVMO 80 mg capsules may interact with certain medications, especially those metabolized by the liver's CYP enzymes. Always consult a healthcare provider before combining RETevmo with other treatments.

RETEVMO 80 mg capsules should be stored as directed by the manufacturer, typically in a cool, dry place away from direct sunlight and out of reach of children.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.